ArticleBritish journal of cancer2013

Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma.

J Keller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.